Related Experiment Video
Updated: Jul 15, 2026

07:00
A Laser-induced Mouse Model of Chronic Ocular Hypertension to Characterize Visual Defects
Published on: August 14, 2013
13.1K
POOR VISUAL OUTCOMES IN SYPHILITIC UVEITIS ASSOCIATED WITH METHAMPHETAMINE USE: A CASE SERIES
Jonathan Thomas1, Harris Ahmed2, Kathryn Halbritter1
1Loma Linda University School of Medicine, Loma Linda, California.
Retinal Cases & Brief Reports
|December 15, 2023
Summary
Methamphetamine use may be linked to infectious syphilitic uveitis. Prompt diagnosis and treatment are crucial for preventing vision loss in affected patients.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Toxicology
Background:
- Syphilitic uveitis presents with varied clinical manifestations, often mimicking other ocular conditions.
- Methamphetamine abuse is a growing public health concern with potential systemic and ocular implications.
Purpose of the Study:
- To investigate the association between methamphetamine use and infectious syphilitic uveitis.
- To review clinical characteristics and outcomes of patients with co-occurring methamphetamine use and syphilitic uveitis.
Main Methods:
- Retrospective chart review of four patients diagnosed with syphilitic uveitis and a history of methamphetamine use.
- Analysis of patient demographics, clinical presentation, diagnostic findings, and visual outcomes.
Main Results:
- Four patients (average age 41.5 years) with methamphetamine use presented with vision loss due to syphilitic uveitis.
- Symptoms included blurry vision, with variable uveitis severity and confirmed methamphetamine use history.
- All patients experienced worsening visual outcomes despite initial diagnosis and treatment.
Conclusions:
- High suspicion for syphilis is essential in patients with uveitis and a history of methamphetamine use.
- Early diagnosis and prompt treatment are critical to prevent irreversible visual decline in this population.
- Barriers to treatment completion and poor visual outcomes highlight the need for integrated care approaches.
Related Concept Videos
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

